Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for SRx Health Solutions (SRXH) over the last 14 years, with Q2 2025 value amounting to $2.9 million.

  • SRx Health Solutions' Depreciation & Amortization (CF) fell 1201.08% to $2.9 million in Q2 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 170.87%. This contributed to the annual value of $1.7 million for FY2023, which is 71.01% down from last year.
  • SRx Health Solutions' Depreciation & Amortization (CF) amounted to $2.9 million in Q2 2025, which was down 1201.08% from $26000.0 recorded in Q1 2025.
  • In the past 5 years, SRx Health Solutions' Depreciation & Amortization (CF) ranged from a high of $3.3 million in Q2 2024 and a low of $26000.0 during Q1 2025
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $419000.0 (2023), whereas its average is $682722.2.
  • Within the past 5 years, the most significant YoY rise in SRx Health Solutions' Depreciation & Amortization (CF) was 68907.36% (2024), while the steepest drop was 9256.59% (2024).
  • SRx Health Solutions' Depreciation & Amortization (CF) (Quarter) stood at $409000.0 in 2021, then increased by 3.91% to $425000.0 in 2022, then fell by 2.12% to $416000.0 in 2023, then soared by 121.15% to $920000.0 in 2024, then skyrocketed by 217.72% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q2 2025, $26000.0 for Q1 2025, and $920000.0 during Q4 2024.